PO21 | PSYCHOLOGICAL IMPACT OF CANCER-ASSOCIATED THROMBOSIS: DUAL BURDEN AND IMPLICATIONS FOR QUALITY OF LIFE AND INTEGRATED PATIENT-CENTERED CARE
Bleeding, Thrombosis and Vascular Biology · 16.04.2026 · 5 (s1)
DOI: 10.4081/btvb.2026.516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bleeding, Thrombosis and Vascular Biology, online erschienen am 16.04.2026. Verfasst von Società Italiana di Emostasi e Trombosi. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Up to 20–60% of cancer patients experience existential distress and need psychological support at diagnosis. Cancer-associated thrombosis (CAT), affecting up to 20% of patients and ranking as the second leading cause of death after cancer progression, imposes major psychological burdens such as fear of death, recurrence anxiety, and reduced health-related quality of life (HRQoL). VTE can trigger post-traumatic stress–like symptoms and persistent health anxiety. CAT consequences remain under-recognized and are worsened by socio-economic factors.
Aim
To evaluate the psychological impact of CAT, its effects on HRQoL, and existing gaps in patient education, medication adherence, and integrated psycho-oncological care. Materials and Methods. A narrative review of qualitative and quantitative studies, clinical cohorts, and mixed-methods research was conducted. Key sources included the PELICAN and ADAM studies, longitudinal cohorts, and randomized trials comparing low-molecular-weight heparins (LMWH) and direct oral anticoagulants (DOACs). Data were extracted on psychological distress, existential anxiety, HRQoL, treatment adherence, and socioeconomic contributors.
Results
Clinically significant existential distress affects up to 46% of patients with advanced cancer. CAT amplifies baseline distress, adds existential anxiety, and reduces HRQoL and social functioning. LMWH is associated with higher emotional burden, whereas DOACs improve convenience and perceived safety. Emotional distress is linked to better adherence. Insufficient CAT-related information increases stress. Socioeconomic disadvantage correlates with greater distress and reduced access to psycho-oncological support. Structured interventions—cognitive-behavioral therapy, meaning-centered therapy, CALM, psychodynamic approaches, and supportive counseling—reduce fear and existential distress while improving HRQoL.
Conclusions
CAT combines life-threatening clinical complications with substantial psychological impact. Optimal management requires systematic psychological assessment, targeted psychotherapeutic interventions, patient-centered education, and attention to socioeconomic disparities. Integrated consultations linking thrombosis care with psycho-oncology may improve outcomes. Addressing remaining gaps requires collaborative trials involving CAT specialists, oncologists, psychotherapists, and quality-of-life experts to ensure equitable and holistic care.
Zitieren
APA
Trombosi, S. I. D. E. E. (2026). PO21 | PSYCHOLOGICAL IMPACT OF CANCER-ASSOCIATED THROMBOSIS: DUAL BURDEN AND IMPLICATIONS FOR QUALITY OF LIFE AND INTEGRATED PATIENT-CENTERED CARE. Bleeding, Thrombosis and Vascular Biology, 5(s1). https://doi.org/10.4081/btvb.2026.516
Vancouver
Trombosi SIDEE. PO21 | PSYCHOLOGICAL IMPACT OF CANCER-ASSOCIATED THROMBOSIS: DUAL BURDEN AND IMPLICATIONS FOR QUALITY OF LIFE AND INTEGRATED PATIENT-CENTERED CARE. Bleeding, Thrombosis and Vascular Biology. 2026;5(s1). doi:10.4081/btvb.2026.516
BibTeX
@article{Trombosi2026,
author = {Trombosi, Società Italiana di Emostasi e},
title = {PO21 | PSYCHOLOGICAL IMPACT OF CANCER-ASSOCIATED THROMBOSIS: DUAL BURDEN AND IMPLICATIONS FOR QUALITY OF LIFE AND INTEGRATED PATIENT-CENTERED CARE},
journal = {Bleeding, Thrombosis and Vascular Biology},
year = {2026},
volume = {5},
number = {s1},
doi = {10.4081/btvb.2026.516}
}
EUVIMED